Type-IIx
Well-known Member
Type-IIx's Gear, Growth, and Gains: New Episode 003: AAS for Untested Powerlifting; AAS & Cardiovascular and Psychological Harms; Women & RhGH vs. GH Secretagogues; Thyroid Function a la AAS & GH
Released 2024-08-15
Download Link
Episode Details & Player
type-iix.podbean.com
Synopsis
I. AAS & Nonhypertrophy Objectives ("Making Weight") for Untested Powerlifters: (i) Increased Strength/Power; (ii) Anticatabolism & Antiadipogenic Effects; (iii) Enhanced Bone & Soft Tissue Metabolism; & (iv) Increased Glycogen Synthetase Activity
II. Curated Biological Harms of AAS: (i) Cardiovascular; (ii) Psychological
III. Female Considerations: GH Secretagogues vs. RhGH, Enhanced Efficacy/Tolerability
IV. Thyroid Function a la (a) AAS and (b) RhGH
Released 2024-08-15
Download Link
Episode Details & Player
![type-iix.podbean.com](/community/proxy.php?image=https%3A%2F%2Fd2bwo9zemjwxh5.cloudfront.net%2Fimage-logo%2F19090227%2FIMG_0249_4hi2pv_1200x628.jpg%3Fs%3Da424bf5c798adac9b31d2b66106d32cd%26e%3Djpeg&hash=52b7fe2154b5369af0fddf000a4641b2&return_error=1)
Type-IIx's Gear, Growth, and Gains: Ep. 004: AAS & Strength/Power (Making Weight); Cardiovascular & Psychological Harms; Female Issues: GH Secretagogues vs. RhGH; Thyroid Function a la AAS & RhGH | Type-IIx: Gear, Growth, and Gains
Title Type-IIx's Gear, Growth, and Gains: Ep. 004: AAS & Strength/Power (Making Weight); Cardiovascular & Psychological Harms; Female Issues: GH Secretagogues vs. RhGH; Thyroid Function a la AAS & RhGH Runtime 25 min Synopsis I. AAS & Nonhypertrophy Objectives ("Making Weight") for Untested...
Synopsis
I. AAS & Nonhypertrophy Objectives ("Making Weight") for Untested Powerlifters: (i) Increased Strength/Power; (ii) Anticatabolism & Antiadipogenic Effects; (iii) Enhanced Bone & Soft Tissue Metabolism; & (iv) Increased Glycogen Synthetase Activity
II. Curated Biological Harms of AAS: (i) Cardiovascular; (ii) Psychological
III. Female Considerations: GH Secretagogues vs. RhGH, Enhanced Efficacy/Tolerability
IV. Thyroid Function a la (a) AAS and (b) RhGH